North America Sleep Aids market is projected to grow by 5.5% annually in the forecast period and reach $53,183.0 million by 2031, driven by the rising geriatric population and increasing incidences of sleep disorders, the increase in awareness about sleep disorders, the advancement of novel sleep aid products, a number of government initiatives to improve public healthcare, the increasing number of healthcare facilities, and the growing usage of portable and wearable sleep apnea devices.
Highlighted with 22 tables and 48 figures, this 109-page report "North America Sleep Aids Market 2021-2031 by Product Type (Smart Bedding, Lab Services, Sleep Apnea Devices, Medication, Wearable Devices, Others), Indication (Insomnia, Sleep Apnea, Narcolepsy, Restless Leg Syndrome, REM Sleep Behavior Disorder, Sleepwalking, Others), Distribution Channel (Drug Stores, E-Commerce, Hospital Pharmacies, Retail Pharmacies), and Country: Trend Forecast and Growth Opportunity" is based on a comprehensive research of the entire North America Sleep Aids market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter's Fiver Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify North America Sleep Aids market in every aspect of the classification from perspectives of Product Type, Indication, Distribution Channel, and Country.
Based on Product Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Smart Bedding
• Sleep Lab Services
• Sleep Apnea Devices
o Adaptive Servo-Ventilators (ASVs)
o Positive Airway Pressure (PAP) Devices
o Oral Appliances
o Facial Interfaces
o Other Sleep Apnea Devices
o Prescription Drugs
o OTC Drugs
o Herbal Drugs
• Wearable Devices
• Other Product Types
Based on Indication, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Sleep Apnea
• Restless Leg Syndrome
• REM Sleep Behavior Disorder
• Other Indications
By Distribution Channel, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Drug Stores
• Hospital Pharmacies
• Retail Pharmacies
Geographically, the following national/local markets are fully investigated:
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Product Type, Indication and Distribution Channel over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Advanced Brain Monitoring Inc.
Apex Medical Corp.
Apnea Sciences Corporation
BMC Medical Co., Ltd.
Braebon Medical Corp.
Cadwell Industries Inc.
Cleveland Medical Devices Inc.
Drive DeVilbiss Healthcare Inc.
Fisher & Paykel Healthcare Corp. Ltd.
Itamer Medical Ltd.
Koninklijke Philips N. V.
Merck & Co., Inc.
Natus Medical Inc.
Nihon Kohden Corporation
Sanofi S. A.
Sleep Number Corporation
Teva Pharmaceutical Industries Ltd.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 Market Overview and Dynamics 18
2.1 Market Size and Forecast 18
2.1.1 Impact of COVID-19 on World Economy 19
2.1.2 Impact of COVID-19 on the Market 21
2.2 Major Growth Drivers 23
2.3 Market Restraints and Challenges 28
2.4 Emerging Opportunities and Market Trends 31
2.5 Porter's Fiver Forces Analysis 35
3 Segmentation of North America Market by Product Type 39
3.1 Market Overview by Product Type 39
3.2 Smart Bedding 41
3.3 Sleep Lab Services 42
3.4 Sleep Apnea Devices 43
3.4.1 Adaptive Servo-Ventilators (ASVs) 45
3.4.2 Positive Airway Pressure (PAP) Devices 46
3.4.3 Oral Appliances 47
3.4.4 Facial Interfaces 48
3.4.5 Other Sleep Apnea Devices 49
3.5 Medication 50
3.5.1 Prescription Drugs 51
3.5.2 OTC Drugs 52
3.5.3 Herbal Drugs 53
3.6 Wearable Devices 54
3.7 Other Product Types 55
4 Segmentation of North America Market by Indication 56
4.1 Market Overview by Indication 56
4.2 Insomnia 58
4.3 Sleep Apnea 59
4.4 Narcolepsy 60
4.5 Restless Leg Syndrome 61
4.6 REM Sleep Behavior Disorder 62
4.7 Sleepwalking 63
4.8 Other Indications 64
5 Segmentation of North America Market by Distribution Channel 65
5.1 Market Overview by Distribution Channel 65
5.2 Drug Stores 67
5.3 E-Commerce 68
5.4 Hospital Pharmacies 69
5.5 Retail Pharmacies 70
6 North America Market 2021-2031 by Country 71
6.1 Overview of North America Market 71
6.2 U.S. 74
6.3 Canada 77
6.4 Mexico 79
7 Competitive Landscape 81
7.1 Overview of Key Vendors 81
7.2 New Product Launch, Partnership, Investment, and M&A 84
7.3 Company Profiles 85
Advanced Brain Monitoring Inc. 85
Apex Medical Corp. 87
Apnea Sciences Corporation 88
BMC Medical Co., Ltd. 89
Braebon Medical Corp. 90
Cadwell Industries Inc. 91
Cleveland Medical Devices Inc. 92
Compumedics Limited 93
Drive DeVilbiss Healthcare Inc. 94
Fisher & Paykel Healthcare Corp. Ltd. 95
GlaxoSmithKline plc 96
Itamer Medical Ltd. 97
Koninklijke Philips N. V. 98
Merck & Co., Inc. 99
Natus Medical Inc. 100
Nihon Kohden Corporation 101
Pfizer Inc. 102
ResMed Inc. 103
Sanofi S. A. 104
Sleep Number Corporation 105
SleepMed Inc. 106
SomnoMed Inc. 107
Teva Pharmaceutical Industries Ltd. 108
RELATED REPORTS 109